
The Journal
Notes on living longer, and better.
A twice-daily field journal on the science of longevity, recovery, and feeling genuinely well — written without the sales pitch.
Between entries, on Instagram.
Long-form lives here on the journal; the short-form notes — protocol tweaks, daily readouts, what’s working this week — go up on Instagram first.
Follow for daily posts
@swcrosbie
Scott Crosbie says GLP-1 drugs are rapidly becoming mainstream for weight, blood sugar, and inflammation control, even curbing cravings and alcohol intake. With few downsides and newer versions, expect widespread adopti…
@swcrosbie
Most people wait until something hurts before they think about their health.
@swcrosbie
The best aesthetic results rarely come from doing more, they come from doing the right things together.
All Entries
112 EntriesReached the end? The daily thread keeps going.
Two posts a day land here. A few more land on Scott’s Instagram — quick notes, behind-the-scenes from the clinic, and the things he’s testing this week before they make it into long form.
Follow for daily posts
@swcrosbie
Scott Crosbie says GLP-1 drugs are rapidly becoming mainstream for weight, blood sugar, and inflammation control, even curbing cravings and alcohol intake. With few downsides and newer versions, expect widespread adopti…
@swcrosbie
Most people wait until something hurts before they think about their health.
@swcrosbie
The best aesthetic results rarely come from doing more, they come from doing the right things together.




















